section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Availability

Route/Dosage

Renal Impairment

Renal Impairment

Renal Impairment

Renal Impairment

US Brand Names

Miplyffa

Action

  • Mechanism by which arimoclomol exerts its therapeutic effects is unknown.
Therapeutic effects:
  • Improvement in ambulation, speech, swallowing, and fine motor skills.

Classifications

Therapeutic Classification: none assigned

Pharmacokinetics

Absorption: Extent of absorption following oral administration unknown.

Distribution: Widely distributed to tissues.

Metabolism/Excretion: Primarily metabolized in the liver via glutathionation and O-glucuronidation. 12% excreted in feces; 78% excreted in urine (42% as unchanged drug).

Half-Life: 4 hr.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown0.5 hr12 hr

Patient/Family Teaching

Pronunciation

ar-IM-oh-KLOE-mol